CClinicalTrials.gg
Sign In
CompletedNCT05261763Updated Apr 22, 2022

Effects of Trigger Point Dry Needling in Individuals With Patello Femoral Pain Syndrome : A Randomized Controlled Trial

An interventional study of Dry Needling and Sham Dry Needing in Patellofemoral Pain Syndrome, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2022-04-22.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Mar 2021, registered Feb 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

A double blinded clinical controlled trial will be performed on individuals with patello femoral pain syndrome in which Trigger Point Dry Needling will be given to experimental group while Sham Needling will be given to the control group, targeting the trigger points present in the Quadriceps of affected individuals assessing the pain,functional disability and range of motion of the affected individuals.

Read the detailed description

A double blinded Randomized Controlled Trial of 6 months study after the approval of synopsis, will be conducted. Convenience sampling technique will be used to enroll the patients. Patients will be selected according to predefined inclusion and exclusion criteria. All patients who fulfill inclusion criteria will be allocated in two group through randomization by lottery method. Group A will receive TrP-DN and group B will receive Sham Needling. Both groups will be asked to perform stretching exercise of Quadriceps daily after needling. The patients' outcomes will be measured by VAS for pain intensity and Kujala Questionnaire for functional status. The comparison between pre-treatment and post-treatment data will be done after 3 months. Informed consents will be taken from each patient. Data entry and analysis will be done with SPSS 23.

02

Conditions studied

  • Patellofemoral Pain Syndrome

Keywords

  • Patellofemoral Pain Syndrome
  • Dry Needling
  • Trigger Points
03

In context

Patellofemoral Pain Syndrome

295 studies on the registry are indexed under Patellofemoral Pain Syndrome; 75 are open to participants now.

This study's enrollment of 70 is above the median of 45 across 242 interventional studies indexed under Patellofemoral Pain Syndrome.

Browse Patellofemoral Pain Syndrome studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    1. Both genders 2. Ages range from 18-40 years 3. They have clinical diagnosis of PFPS (the diagnosis was confirmed by a positive patellar grind test and tenderness of medial and lateral patellar facets) 4. Participants are also required to have a minimum pain score of 3 on Numeric Pain Scale 5. Kujala patellofemoral questionnaire score of 50 to 80 before the intervention.
  1. Patients willing to participate

Exclusion criteria

Exclusion Criteria:

  • History of any following conditions

    1. Participants who have received any treatment for PFPS within the 3 months
    2. A history of lower extremities fracture or surgery
    3. Presence of MSK diseases such as Acute Herniated Disc or Spondylolisthesis
    4. History of any chronic disease e.g. Diabetes Mellitus
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Active comparator
    Group A

    Group A will receive trigger point dry needling in quadricep muscles

    Other: Dry Needling

  • Sham comparator
    Group B

    Group B will get Sham needling in quadriceps muscles

    Other: Sham Dry Needing

Interventions

  • OtherDry Needling

    abc

  • OtherSham Dry Needing

    xyz

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale

    Visual Analogue Scale

    Time frame: 8th week

  2. Kujala Questionnaire

    functional disability will be check by Kujala Questionnaire

    Time frame: 8th week

  3. Goniometer

    range of motion will be checked by Goniometer

    Time frame: 8th week

07

Study locations

1 site
  • Riphah International University
    Faisalabad, Punjab 38000, Pakistan
08

References and documents

Publications

  • Neal BS, Lack SD, Lankhorst NE, Raye A, Morrissey D, van Middelkoop M. Risk factors for patellofemoral pain: a systematic review and meta-analysis. Br J Sports Med. 2019 Mar;53(5):270-281. doi: 10.1136/bjsports-2017-098890. Epub 2018 Sep 21. PubMed 30242107 ↗
  • Erratum: Effects of Trigger Point Dry Needling on Neuromuscular Performance and Pain of Individuals Affected by Patellofemoral Pain: A Randomized Controlled Trial [Corrigendum]. J Pain Res. 2020 Sep 7;13:2237. doi: 10.2147/JPR.S278493. eCollection 2020. PubMed 32982385 ↗
  • Mason JS, Crowell M, Dolbeer J, Morris J, Terry A, Koppenhaver S, Goss DL. THE EFFECTIVENESS OF DRY NEEDLING AND STRETCHING VS. STRETCHING ALONE ON HAMSTRING FLEXIBILITY IN PATIENTS WITH KNEE PAIN: A RANDOMIZED CONTROLLED TRIAL. Int J Sports Phys Ther. 2016 Oct;11(5):672-683. PubMed 27757280 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05261763
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Mar 2, 2022
Start date
Mar 15, 2021
Primary completion
Mar 1, 2022
Completion
Mar 1, 2022
Last update
Apr 22, 2022

Study contacts

Muhammad Kashif
study chair · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Patellofemoral Pain Syndrome→

Other studies from this sponsor

Riphah International University

Start the discussion